文献速递肝病消化道肿瘤与早癌

得克萨斯肝细胞癌风险指数预测模型在亚洲队列中的验证

Validation of the Texas Hepatocellular Carcinoma Risk Index Predictive Model for Hepatocellular Carcinoma in Asian Cohort.
PubMed 文献 · Clin Gastroenterol Hepatol · 2024-03-13

本研究旨在评估原本在西方人群开发的得克萨斯肝细胞癌风险指数(THCC-RI)预测模型在东方背景下的跨区域适用性与准确性,原文未报告具体研究设计与结果数据。

要点

  • 评估THCC-RI预测模型在亚洲队列中的跨区域适用性与准确性。
  • 原文指出HBV、HCV感染和饮酒等风险因素流行率的东西方差异影响模型外推。
  • 原文未报告验证队列的样本量、判别力或校准度结果。

核心结论

  • 原文未报告THCC-RI模型在亚洲队列中的验证结论。

研究设计与样本

  • 原文未报告具体研究设计与样本量。

主要发现

  • 原文未报告验证队列的主要发现。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatocellular carcinoma (HCC) represents a significant global health burden, with its incidence and mortality rates varying significantly across different geographic regions. This variance is largely attributed to differences in the prevalence of risk factors such as hepatitis B and C infections, and alcohol consumption, as well as genetic predispositions that are distinct between Eastern and Western populations. Moreover, the impact of racial and ethnic diversity on the disease's epidemiology further complicates the global understanding and prediction of HCC. Such disparities highlight the critical need to evaluate the applicability of predictive models across diverse populations, acknowledging that a model developed in one region may not necessarily translate with the same accuracy or effectiveness when applied to another, because of these underlying epidemiologic and genetic differences. In this study, we aimed to assess the cross-regional applicability and accuracy of an HCC prediction model (Texas hepatocellular carcinoma risk index [THCC-RI] predictive model) originally developed in Western populations, within an Eastern context.1,2.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Yoo JJ, Song YG, Moon JE, et al. Validation of the Texas Hepatocellular Carcinoma Risk Index Predictive Model for Hepatocellular Carcinoma in Asian Cohort. Clin Gastroenterol Hepatol. 2024. PMID: 38484945. doi:10.1016/j.cgh.2024.02.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。